LAURIE POTTER: Open Payments
NPI 1720566565 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 20 payments from 9 companies in 2025. Trend: 2023 $702 · 2024 $496 · 2025 $652
Food & beverage: $618Education: $34
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $147 |
| AstraZeneca Pharmaceuticals LP | 5 | $103 |
| Lilly USA, LLC | 1 | $98 |
| Novartis Pharmaceuticals Corporation | 3 | $76 |
| GENZYME CORPORATION | 3 | $72 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $56 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Amgen Inc. | 1 | $34 |
| Optinose US, Inc. | 1 | $22 |
Products named: DUPIXENT, TEZSPIRE, EBGLYSS, NEFFY, TRELEGY ELLIPTA, Rhapsido, Xhance, XOLAIR.
Industry payments across TN — which companies pay providers there.
